Sionna Therapeutics, Inc. (SION) Earnings History
Annual and quarterly earnings data from 2022 to 2025
Loading earnings history...
SION EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SION Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
Download Data
Export SION earnings history in CSV or JSON format
Free sign-in required to download data
Sionna Therapeutics, Inc. (SION) Earnings Overview
As of May 8, 2026, Sionna Therapeutics, Inc. (SION) reported trailing twelve-month net income of -$75M, reflecting -34.3% year-over-year growth. The company earned $-1.88 per diluted share over the past four quarters.
Looking at the long-term picture, SION's historical earnings data spans multiple years. The company achieved its highest annual net income of -$40M in fiscal 2022.
Sionna Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including VRTX ($4.34B net income, 32.7% margin), ABBV ($4.23B net income, 6.9% margin), PTCT (-$187M net income, 39.4% margin), SION has comparable earnings metrics. Compare SION vs VRTX →
SION Earnings vs Peers
Earnings metrics vs comparable public companies
SION Historical Earnings Data (2022–2025)
4 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$75M | -22.0% | -$89M | $-1.88 | - | - |
| 2024 | -$62M | -30.5% | -$71M | $-1.40 | - | - |
| 2023 | -$47M | -17.5% | -$50M | $-1.07 | - | - |
| 2022 | -$40M | - | -$41M | $-0.91 | - | - |
See SION's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SION Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SION vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSION — Frequently Asked Questions
Quick answers to the most common questions about buying SION stock.
Is SION growing earnings?
SION EPS fell to $-1.88, with earnings declining -34.3%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-75M.
What are SION's profit margins?
Sionna Therapeutics, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are SION's earnings?
SION earnings data spans 2022-2025. The declining earnings trend is -34.3% YoY. Historical data enables comparison across business cycles.